Drug Trial Radar · NCT06462235
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infants and Newborns Admitted in Hospitals With Bacterial Infection (CHERISH)
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
48
Planned (sponsor's estimate)
Start
Sep 25, 2024
Primary completion
Apr 25, 2027
Study completion Apr 25, 2027
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- Collaborators
- AbbVie
- First posted
- Jun 17, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Basic science
- FDA-regulated drug
- Yes
- Who can join
- All sexes, up to 39 weeks
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to learn about the safety and effects of ATM-AVI for the possible treatment of infections caused by a type of bacteria called gram-negative bacteria. The study medicine is a combination of an antibiotic, aztreonam (ATM), and another medicine, avibactam (AVI), which is used to help stop bacteria from being resistant to antibiotics. Antibiotics are medicines that fights bacteria and infections. The study will include newborns and infants up to 9 months of age who are admitted in the hospital. The study is conducted in 2 parts: Part A and Part B. In Part A, all participants will receive a single intravenous (injected directly into a vein) infusion of ATM-AVI. This is to study the safety and effects of a single amount. In Part B, all participants will receive multiple intravenous infusions of ATM-AVI as treatment for a possible or confirmed infection with gram-negative bacteria.
Conditions
- Gram-negative Bacterial Infection
Interventions
Part A: ATM-AVI Single Dose, Cohorts 1-4Drug
Single intravenous infusion of aztreonam-avibactam over 3 hours to assess pharmacokinetics, safety, and toleration.
Part B: Multiple-dose ATM-AVI, Cohorts 1-4Drug
Multiple intravenous infusions of aztreonam-avibactam over 3 hours, repeated every 6-8 hours up to 14 days to assess pharmacokinetics, safety, toleration, and efficacy.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Maximum Predicted Plasma Concentration (Cmax) of ATM and AVITime frame: Up to Day 15
- Area under the Concentration-Time Curve (AUC) of ATM-AVITime frame: Up to Day 15
- Plasma Elimination Half-Life (t1/2)Time frame: Up to Day 15
- Apparent Clearance (CL)Time frame: Up to Day 15
- Plasma concentrations of ATM and AVI by nominal sampling timeTime frame: Up to Day 15
- Proportion of Participants reporting Adverse Events (AE)Time frame: Baseline up to Day 50
- Proportion of Participants reporting Serious Adverse Events (SAE)Time frame: Baseline up to Day 50
- Proportion of Participants reporting AEs leading to discontinuation of study drugTime frame: Baseline up to Day 50
- Proportion of Participants reporting AEs resulting in deathTime frame: Baseline up to Day 50
- Proportion of Participants reporting liver injury and acute kidney injuryTime frame: Baseline up to Day 50
Locations
36 sites in 10 countries. Site status is shown where the registry gives one.
Children's Hospital of Orange County Southwest Tower
Orange, California · Recruiting
Children's Hospital of Orange County
Orange, California · Recruiting
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Riley Hospital for Children at Indiana University Health
Indianapolis, Indiana · Recruiting
Norton Children's Hospital
Louisville, Kentucky · Recruiting
Novak Center for Children's Health
Louisville, Kentucky · Recruiting
University of Louisville, Norton Children's Research Institute
Louisville, Kentucky · Recruiting
Tufts Medical Center
Boston, Massachusetts · Recruiting
Duke University - Main Hospital and Clinics
Durham, North Carolina · Recruiting
Memorial Hermann Hospital - Texas Medical Center
Houston, Texas · Recruiting
The University of Texas Health Science Center at Houston
Houston, Texas · Recruiting
Sanatorio Sagrado Corazón
Ciudad Autónoma de Buenos Aires, Buenos Aires, Argentina · Recruiting
Clinica Del Niño Y La Madre
Mar del Plata, Buenos Aires, Argentina · Recruiting
Clinica Privada del Sol S.A
Córdoba, Córdoba Province, Argentina · Recruiting
Hospital del Niño Jesús
San Miguel de Tucumán, Tucumán Province, Argentina · Recruiting
UMHAT Deva Maria
Burgas, Bulgaria · Recruiting
Umhat Kanev
Rousse, Bulgaria · Recruiting
Acibadem City Clinic University Multiprofile Hospital for Active Treatment Tokuda EAD
Sofia, Bulgaria · Recruiting
University General Hospital of Heraklion
Heraklion, Irakleío, Greece · Recruiting
Ippokrateio General Hospital of Thessaloniki
Thessaloniki, Kentrikí Makedonía, Greece · Recruiting
Nirmal Hospital Pvt Ltd.
Surat, Gujarat, India · Recruiting
RajaRajeswari Medical College and Hospital
Bengaluru, Karnataka, India · Recruiting
Sahyadri Super Speciality Hospital
Pune, Maharashtra, India · Recruiting
Medanta Hospital Lucknow
Lucknow, Uttar Pradesh, India · Recruiting
Institute of Child Health
Kolkata, West Bengal, India · Recruiting
Schneider Children's Medical Center
Petah Tikva, Central District, Israel · Recruiting
Rambam Health Care Campus
Haifa, Northern District, Israel · Recruiting
Azienda Ospedaliera Universitaria Meyer IRCCS
Florence, Florence, Italy · Recruiting
Hospital Civil Fray Antonio Alcalde
Guadalajara, Jalisco, Mexico · Not yet recruiting
Hospital Universitario 12 de Octubre
Madrid, Spain · Not yet recruiting
Hospital Sant Joan de Déu
Esplugues de Llobregat, Barcelona [barcelona], Spain · Recruiting
Hospital Universitario La Paz
Madrid, Madrid, Comunidad de, Spain · Recruiting
Taichung Veterans General Hospital
Taichung, Taiwan · Recruiting
Chang Gung Medical Foundation Linkou Chang Gung Memorial Hospital
Taoyuan, Taiwan · Recruiting
Hsinchu Municipal Mackay Children's Hospital
Hsinchu, Hsinchu, Taiwan · Recruiting
Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Hualien City, Hualien, Taiwan · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.